Future expectations in the prophylaxis of intestinal bleeding.

Klebl, F H; Schölmerich, J

Klebl, F H; Schölmerich, J.

Affiliation

Klebl FH; Department of Internal Medicine I, University of Regensburg, D-93042 Regensburg, Germany. frank.klebl@klinik.uni-regensburg.de

Best Pract Res Clin Gastroenterol ; 22(2): 373-87, 2008.

Article in En | MEDLINE | ID: mdl-18346690

Subject(s)

Gastrointestinal Hemorrhage/prevention & control; Adrenergic beta-Antagonists/therapeutic use; Anti-Inflammatory Agents, Non-Steroidal/adverse effects; Anti-Ulcer Agents/therapeutic use; Critical Illness; Forecasting; Gastrointestinal Hemorrhage/etiology; Hemostasis, Endoscopic; Humans; Primary Prevention; Risk Factors; Vasoconstrictor Agents/therapeutic use

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Gastrointestinal Hemorrhage Type of study: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Best Pract Res Clin Gastroenterol Journal subject: GASTROENTEROLOGIA Year: 2008 Type: Article Affiliation country: Germany

Fulltext

XML

PubMed Links

Search on Google